Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.

% pred, number of adult pwCF and survival over the last decade only in European higher and middle income countries. Urgent action is needed in the lower income countries where such improvement was not observed. The notable improvement observed in pwCF carrying the F508del mutation emphasises the need to develop treatments for all CF mutations.